Inmolecule Nanotech (XPAR:MLINA) Net Margin %: -11.51% (As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Net Margin %?

Inmolecule Nanotech XPAR:MLINA 6 Net Margin % is -11.51% as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review. Among 944 Biotechnology companies, Inmolecule Nanotech ranks better than 65.36% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Inmolecule Nanotech's Net Income for the six months ended in Dec. 2024 was €-0.23 Mil. Inmolecule Nanotech's Revenue for the six months ended in Dec. 2024 was €1.98 Mil. Therefore, Inmolecule Nanotech's net margin for the quarter that ended in Dec. 2024 was -11.51%.

The historical rank and industry rank for Inmolecule Nanotech's Net Margin % or its related term are showing as below:

XPAR:MLINA' s Net Margin % Range Over the Past 10 Years
Min: -106.61   Med: -59.06   Max: -11.51
Current: -11.51

XPAR:MLINA's Net Margin % is ranked better than
65.36% of 944 companies
in the Biotechnology industry
Industry Median: -88.815 vs XPAR:MLINA: -11.51

Inmolecule Nanotech  (XPAR:MLINA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Inmolecule Nanotech Net Margin % Related Terms

Inmolecule Nanotech Net Margin % Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Net Margin % Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Net Margin %
-106.61 -11.51

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Net Margin % -106.61 -11.51

XPAR:MLINA vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Inmolecule Nanotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inmolecule Nanotech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inmolecule Nanotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Inmolecule Nanotech's Net Margin % falls into.


XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Inmolecule Nanotech's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-0.228/1.981
=-11.51 %

Inmolecule Nanotech's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-0.228/1.981
=-11.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -11.51% mean?
Inmolecule Nanotech (XPAR:MLINA) has a Net Margin % of -11.51% as of Dec. 2024. Net margin is the ratio of total net income to net sales. View historical data on Inmolecule Nanotech and its competitors. According to the industry distribution chart, Inmolecule Nanotech ranks #327 out of 944 companies in the Biotechnology industry, placing it in the top 34.6%.
Is Inmolecule Nanotech's Net Margin % too high?
Inmolecule Nanotech's current Net Margin % is -11.51%. Based on the distribution chart, Inmolecule Nanotech ranks #327 out of 944 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Inmolecule Nanotech ranks #327 out of 944 companies for Net Margin %. This puts Inmolecule Nanotech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Net Margin % is -11.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Net Margin % of -11.51%. The current Net Margin % is -11.51%. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Net Margin % is -11.51% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price